Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
about
Membranous nephropathy: thinking through the therapeutic options.Plasma cells as an innovative target in autoimmune disease with renal manifestations.Treatment of membranous nephropathy: time for a paradigm shift.Treatment of primary membranous nephropathy: where are we now?The clinicopathological features of patients with membranous nephropathy.
P2860
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
@en
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
@nl
type
label
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
@en
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
@nl
prefLabel
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
@en
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
@nl
P2093
P2860
P1476
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.
@en
P2093
Choli Hartono
Miriam Chung
Sheng F Kuo
Surya V Seshan
Thangamani Muthukumar
P2860
P2888
P304
P356
10.1007/S40620-013-0028-X
P577
2014-01-16T00:00:00Z